查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1570831

動物用藥品複合市場：依產品、形式、管理、動物、最終用戶 - 2025-2030 年全球預測

Animal Drug Compounding Market by Product (Anti-Infective Agents, Anti-Inflammatory Agents, Central Nervous System (CNS) Agents), Form (Capsules, Creams & Gels, Ointments), Administration, Animal, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年動物用藥品復配市場價值為11.9億美元，預計到2024年將達到12.8億美元，複合年成長率為9.98%，到2030年將達到23.3億美元。

動物用藥品複配是指在市售藥物不足的情況下，為滿足動物的特定需求和情況而配製定製化藥物。這種做法是必要的，因為動物的大小、種類和特定的健康需求各不相同，而標準藥物可能無法滿足這些需求。例如，較大的動物（例如馬）可能需要與較小的動物（例如貓和狗）不同的劑量，並且某些動物可能對某些配方或香料有過敏反應。主要用途包括改變劑量、改變劑型（例如從錠劑到液體）以及添加調味劑以使藥物更偏好。最終用途包括獸醫院、獸醫診所和牲畜管理設施。市場成長受到全球寵物擁有量的增加、動物慢性疾病的增加以及獸醫學中對更個人化醫療的需求的影響。此外，藥物配方的進步使得藥物組合變得更加精確和有效，從而推動了進一步的需求。目前的商機包括擴展到獸醫學不斷發展的新興市場，以及利用科技實現更精確的處方。然而，仍然存在可能阻礙成長的挑戰，例如 FDA 等機構的監管障礙以及維持嚴格的品管標準。確保不同物種藥物的安全性和有效性的複雜性使市場擴張更加複雜。創新可以圍繞創建更有效率的複合過程、開發更環保、更安全的配方，並利用數位工具實現更準確的劑量。探索替代配方材料和詐欺包裝也可能提供競爭優勢。與獸醫機構的研究和開發合作夥伴夥伴關係可以提供重要的見解並擴大市場基礎。最終，我們相信，對個人化動物照護和全球擴大策略的關注對於市場領導者來說至關重要。

主要市場統計
基準年[2023] 11.9億美元
預測年份 [2024] 12.8億美元
預測年份 [2030] 23.3億美元
複合年成長率（%） 9.98%

市場動態：揭示快速發展的動物用藥品復配市場的關鍵市場洞察

供需的動態交互作用正在改變動物用藥品復配市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，以及消費行為及其對製造成本的影響及其對採購趨勢的影響。

波特五力：駕馭動物用藥品復配市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解動物用藥品復配市場的外部影響

外部宏觀環境因素在塑造動物用藥品製劑市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解動物用藥品復配市場競爭狀況

動物用藥品製劑市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣動物用藥品復配市場供應商的績效評估

FPNV定位矩陣是評估動物用藥品復配市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃動物用藥品復配市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對動物用藥品製劑市場進行策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告提供了涵蓋主要焦點細分市場的全面市場分析。

1. 市場滲透率：對當前市場環境的詳細回顧。

2. 市場開拓：辨識新興市場的成長機會，評估現有產業的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢視市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球寵物主人數量的數量不斷增加，寵物飼主也越來越願意在寵物身上花錢。
      • 寵物慢性疾病的增加和對特定藥物的需求
      • 在世界各地擴大獸醫診所和藥房
    • 抑制因素
      • 配方工藝複雜，需熟練人員
    • 機會
      • 動物醫藥醫藥理學創新與給藥技術進步
      • 與獸醫院、寵物保險公司、研究機構建立策略聯盟
    • 任務
      • 對動物用藥品製劑安全性和有效性的擔憂
  • 市場區隔分析
    • 產品：需要發炎藥物來應對發炎疾病的流行
    • 最終使用者：在獸醫診所和醫院治療的各種物種和各種醫療狀況
  • 波特五力分析
  • PESTLE分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章動物用藥品復配市場：依產品

  • 介紹
  • 抗感染劑
  • 發炎劑
  • 中樞神經系統 (CNS) 藥物
  • 胃腸醫學

第7章動物用藥品複方市場：依形式

  • 介紹
  • 膠囊
  • 霜和凝膠
  • 軟膏
  • 暫停

第8章動物用藥品復配市場：按劑量

  • 介紹
  • 注射
  • 口服
  • 局部的

第9章動物用藥品複方市場：依動物分類

  • 介紹
  • 伴同性動物
  • 大型動物
  • 家畜

第10章動物用藥品配製市場：依最終用戶分類

  • 介紹
  • 牛養殖
  • 寵物飼主
  • 家禽養殖
  • 動物診所和醫院

第11章：美洲動物用藥品復配市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太動物用藥品復配市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲動物用藥品復配市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Surescripts 和 DAW Systems 之間的策略合作夥伴關係為獸醫提供電子處方，提高寵物護理的效率和合規性
    • Mixlab 在 Vanterra Ventures 的支持下收購了 NexGen Animal Health，以擴大大型動物的複合服務
    • Veterinary Pharmaceutical Solutions 透過收購 Diamond Animal Health 鞏固市場地位
  • 戰略分析和建議
Product Code: MRR-3204321AF708

The Animal Drug Compounding Market was valued at USD 1.19 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 9.98%, to USD 2.33 billion by 2030.

Animal drug compounding refers to the customized preparation of medications for animals, tailored to specific needs and circumstances when commercially available drugs do not suffice. This practice is necessary due to the varied sizes, species, and specific health needs of animals, which standard forms of medication may not fulfill. For instance, large animals like horses may require a different dose compared to smaller animals such as cats or dogs, and some animals may have allergic reactions to certain formulations or flavors. The primary applications include altering drug dosages, changing medication formats (such as from a pill to a liquid), and adding flavors to make medications more palatable. End-use scopes encompass veterinary clinics, animal hospitals, and livestock management facilities. Market growth is influenced by the increasing pet ownership globally, the rise of chronic diseases in animals, and the need for more personalized medicine in veterinary care. Moreover, advancements in pharmaceutical formulations have enabled more precise and effective compounded drugs, driving further demand. Current opportunities include expanding into emerging markets where veterinary health care is growing, and leveraging technology for more accurate formulations. However, challenges persist, including regulatory hurdles imposed by agencies like the FDA and maintaining stringent quality control standards, which can inhibit growth. The complexity of ensuring drug safety and efficacy for varied species further complicates market expansion. Innovations can revolve around creating more efficient compounding processes, developing eco-friendly and safe formulations, and utilizing digital tools for better dosage accuracy. Research into alternative compounding materials and tamper-proof packaging may also offer competitive advantages. Entering collaborative partnerships with veterinary institutions for research and development could provide critical insights and broaden the market reach. Ultimately, a focus on personalized animal care and global expansion strategies could prove pivotal for market leaders.

KEY MARKET STATISTICS
Base Year [2023] USD 1.19 billion
Estimated Year [2024] USD 1.28 billion
Forecast Year [2030] USD 2.33 billion
CAGR (%) 9.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Drug Compounding Market

The Animal Drug Compounding Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in pet ownership globally, coupled with the growing willingness of pet owners to spend on their pets
    • Increase in chronic conditions in pets and need for specific medications
    • Expansion of veterinary clinics and pharmacies across the world
  • Market Restraints
    • Complexities in the compounding process and the need for skilled personnel
  • Market Opportunities
    • Innovations in veterinary pharmacology and advancements in drug delivery technologies
    • Establishment of strategic alliances with veterinary clinics, animal hospitals, pet insurance companies, and research institutions
  • Market Challenges
    • Concerns related to the safety and efficacy of animal drug compounding

Porter's Five Forces: A Strategic Tool for Navigating the Animal Drug Compounding Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Drug Compounding Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Drug Compounding Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Drug Compounding Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Drug Compounding Market

A detailed market share analysis in the Animal Drug Compounding Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Drug Compounding Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Drug Compounding Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Drug Compounding Market

A strategic analysis of the Animal Drug Compounding Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Drug Compounding Market, highlighting leading vendors and their innovative profiles. These include Akina Animal Health, Aurora Compounding Pharmacy, Caringbah Compounding Pharmacy, Central Compounding Center South, Chiron Compounding Pharmacy, Inc, Custom-Med Compounding Pharmacy, Davis Islands Pharmacy, Dougherty's Pharmacy, Inc, Hoye's Pharmacy, Medisca Inc., MEDS Canadian Compounding Pharmacy, Millers Pharmacy, Pace Pharmacy, People's Choice of Pharmacy, Pratt's Compounding Pharmacy, Sixth Avenue Medical Pharmacy, Smith Caldwell Drug Store by Walgreen Co., Specialist Compounding Pharmacy Pte Ltd, Tache Pharmacy & Medical Supplies, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy, Victoria Compounding Pharmacy, Vimian Group AB, Wedgewood Pharmacy, and Wellness Pharmacy of Cary.

Market Segmentation & Coverage

This research report categorizes the Animal Drug Compounding Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Anti-Infective Agents, Anti-Inflammatory Agents, Central Nervous System (CNS) Agents, and Gastro-Intestinal(GI) Drugs.
  • Based on Form, market is studied across Capsules, Creams & Gels, Ointments, and Suspension.
  • Based on Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Animal, market is studied across Companion Animals, Large Animals, and Livestock Animals.
  • Based on End-User, market is studied across Cattle Rearing, Pet Owners, Poultry Businesses, and Veterinary Clinics & Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in pet ownership globally, coupled with the growing willingness of pet owners to spend on their pets
      • 5.1.1.2. Increase in chronic conditions in pets and need for specific medications
      • 5.1.1.3. Expansion of veterinary clinics and pharmacies across the world
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the compounding process and the need for skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in veterinary pharmacology and advancements in drug delivery technologies
      • 5.1.3.2. Establishment of strategic alliances with veterinary clinics, animal hospitals, pet insurance companies, and research institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to the safety and efficacy of animal drug compounding
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Need for anti-inflammatory agents to cater to the high prevalence of inflammatory conditions
    • 5.2.2. End-User: Extensive range of species and wide variety of medical conditions treated in veterinary clinics and hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Drug Compounding Market, by Product

  • 6.1. Introduction
  • 6.2. Anti-Infective Agents
  • 6.3. Anti-Inflammatory Agents
  • 6.4. Central Nervous System (CNS) Agents
  • 6.5. Gastro-Intestinal(GI) Drugs

7. Animal Drug Compounding Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Creams & Gels
  • 7.4. Ointments
  • 7.5. Suspension

8. Animal Drug Compounding Market, by Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Animal Drug Compounding Market, by Animal

  • 9.1. Introduction
  • 9.2. Companion Animals
  • 9.3. Large Animals
  • 9.4. Livestock Animals

10. Animal Drug Compounding Market, by End-User

  • 10.1. Introduction
  • 10.2. Cattle Rearing
  • 10.3. Pet Owners
  • 10.4. Poultry Businesses
  • 10.5. Veterinary Clinics & Hospitals

11. Americas Animal Drug Compounding Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Animal Drug Compounding Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Animal Drug Compounding Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Strategic Partnership Between Surescripts and DAW Systems Enhances Veterinary e-Prescribing, Boosts Efficiency and Medication Adherence in Pet Care
    • 14.3.2. Mixlab Acquires NexGen Animal Health to Expand Compounding Services to Large Animals with Vanterra Ventures' Backing
    • 14.3.3. Veterinary Pharmaceutical Solutions Strengthens Market Position with Acquisition of Diamond Animal Health
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akina Animal Health
  • 2. Aurora Compounding Pharmacy
  • 3. Caringbah Compounding Pharmacy
  • 4. Central Compounding Center South
  • 5. Chiron Compounding Pharmacy, Inc
  • 6. Custom-Med Compounding Pharmacy
  • 7. Davis Islands Pharmacy
  • 8. Dougherty's Pharmacy, Inc
  • 9. Hoye's Pharmacy
  • 10. Medisca Inc.
  • 11. MEDS Canadian Compounding Pharmacy
  • 12. Millers Pharmacy
  • 13. Pace Pharmacy
  • 14. People's Choice of Pharmacy
  • 15. Pratt's Compounding Pharmacy
  • 16. Sixth Avenue Medical Pharmacy
  • 17. Smith Caldwell Drug Store by Walgreen Co.
  • 18. Specialist Compounding Pharmacy Pte Ltd
  • 19. Tache Pharmacy & Medical Supplies
  • 20. Triangle Compounding Pharmacy
  • 21. Vertisis Custom Pharmacy
  • 22. Victoria Compounding Pharmacy
  • 23. Vimian Group AB
  • 24. Wedgewood Pharmacy
  • 25. Wellness Pharmacy of Cary

LIST OF FIGURES

  • FIGURE 1. ANIMAL DRUG COMPOUNDING MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL DRUG COMPOUNDING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ANIMAL DRUG COMPOUNDING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ANIMAL DRUG COMPOUNDING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL DRUG COMPOUNDING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL DRUG COMPOUNDING MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANTI-INFECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM (CNS) AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY GASTRO-INTESTINAL(GI) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CREAMS & GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CATTLE REARING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY POULTRY BUSINESSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. ANIMAL DRUG COMPOUNDING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. ANIMAL DRUG COMPOUNDING MARKET, FPNV POSITIONING MATRIX, 2023